NDC 48951-5069

Ignatia Bryophyllum

Ignatia Bryophyllum

Ignatia Bryophyllum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Uriel Pharmacy Inc.. The primary component is Kalanchoe Daigremontiana Leaf; Strychnos Ignatii Seed; Silver; Lachesis Muta Venom.

Product ID48951-5069_6ce1e6f9-6bb3-8bee-e053-2991aa0ac157
NDC48951-5069
Product TypeHuman Otc Drug
Proprietary NameIgnatia Bryophyllum
Generic NameIgnatia Bryophyllum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2009-09-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameUriel Pharmacy Inc.
Substance NameKALANCHOE DAIGREMONTIANA LEAF; STRYCHNOS IGNATII SEED; SILVER; LACHESIS MUTA VENOM
Active Ingredient Strength3 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 48951-5069-2

1350 PELLET in 1 BOTTLE, GLASS (48951-5069-2)
Marketing Start Date2009-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 48951-5069-2 [48951506902]

Ignatia Bryophyllum PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-09-01

Drug Details

Active Ingredients

IngredientStrength
KALANCHOE DAIGREMONTIANA LEAF3 [hp_X]/1

OpenFDA Data

SPL SET ID:ea55cb22-9ca5-4f68-840f-f225c8fbf112
Manufacturer
UNII

NDC Crossover Matching brand name "Ignatia Bryophyllum" or generic name "Ignatia Bryophyllum"

NDCBrand NameGeneric Name
48951-5068Ignatia BryophyllumIgnatia Bryophyllum
48951-5069Ignatia BryophyllumIgnatia Bryophyllum
48951-8306Ignatia BryophyllumIgnatia Bryophyllum

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.